Maria Gustafsson, a doctoral student and clinical pharmacist in the department of community medicine and rehabilitation at Umea University, carried out a randomized, controlled trial among 460 people from 65 years and above suffering from dementia and cognitive impairment.
Here are three points:
1. Before the study intervention was performed, researchers found as many as 41 percent of all admissions were related to medication events.
2. The most common problem was adverse drug reaction, but excessively high dosage and noncompliance was also unfortunately common.
3. The results after the intervention showed that clinical pharmacists’ participation in healthcare teams reduced the risk of drug-related hospital readmissions by half during the follow-up time of 180 days.
More articles on quality & infection control:
5 benefits of e-prescriptions
Ditching shorthand: Minnesota physicians offer clinical note access to patients
Congress to take $500M from Ebola budget; divert funds to combat Zika virus — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.